NeoLight, a leading provider of innovative medical devices and technologies, today announced the appointment of Jim Heath to its Board of Directors. Heath brings over three decades of experience in the medical device industry, including leadership positions at Stryker Corporation.
"We are thrilled to welcome Jim to our Board of Directors," said Vivek Kopparthi, NeoLight Co-founder & CEO. "His extensive experience in sales, marketing, strategic planning, and other key business functions will be invaluable as we continue to expand our product portfolio and enter new markets."
Heath's distinguished career in the medical device industry spans over three decades, holding various leadership positions and driving innovation and growth. He served as President of Stryker's Instruments Division, overseeing a global business with sales exceeding $1.8 billion. During his tenure the division increased revenue, improved profitability, and enhanced employee engagement.
Additionally, he served as COO of Flexfab LLC, a privately-owned manufacturer of silicone, elastomer, and composite materials, where he achieved record sales and implemented strategic initiatives to enhance efficiency and growth.
"I am excited to join the NeoLight Board of Directors and contribute to the company's continued growth and success," said Jim Heath. "NeoLight is a leader in the development of innovative medical devices that are making a real difference in the lives of patients. I look forward to working with the team to build on this success."
Heath currently serves on the Board of Directors for several companies, including C2Dx, AA Medical, Imperial Beverage, and CSM. He holds a Master of Business Administration degree from the University of Notre Dame, a Master of Arts degree in Education from The Ohio State University and a Bachelor of Arts degree from Kalamazoo College.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
